CapsoVision, Inc. Common Stock (CV)vsDexCom Inc (DXCM)
CV
CapsoVision, Inc. Common Stock
$6.32
-2.17%
HEALTHCARE · Cap: $353.85M
DXCM
DexCom Inc
$86.23
-0.07%
HEALTHCARE · Cap: $33.72B
Smart Verdict
WallStSmart Research — data-driven comparison
DexCom Inc generates 35673% more annual revenue ($4.97B vs $13.89M). DXCM leads profitability with a 20.1% profit margin vs -214.7%. DXCM earns a higher WallStSmart Score of 74/100 (B).
CV
Avoid16
out of 100
Grade: F
DXCM
Strong Buy74
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CV.
Margin of Safety
+90.0%
Fair Value
$680.73
Current Price
$86.23
$594.50 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Every $100 of equity generates 38 in profit
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 24.3%
Earnings expanding 43.6% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Trading at 24.3x book value
Premium valuation, high expectations priced in
Trading at 12.4x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : CV
The strongest argument for CV centers on Debt/Equity.
Bull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 24.3%. Revenue growth of 13.1% demonstrates continued momentum.
Bear Case : CV
The primary concerns for CV are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Key Dynamics to Monitor
CV profiles as a turnaround stock while DXCM is a mature play — different risk/reward profiles.
DXCM is growing revenue faster at 13.1% — sustainability is the question.
DXCM generates stronger free cash flow (185M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DXCM scores higher overall (74/100 vs 16/100), backed by strong 20.1% margins and 13.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CapsoVision, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company is headquartered in Saratoga, California.
Visit Website →DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?